Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02451423
Title Study of MPDL3280A in Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.